Gilead Sciences

Gilead Sciences is a biopharmaceutical company that focuses on discovering, developing, and commercializing innovative therapeutics in areas of unmet medical need. They generate revenue primarily through the sale of prescription drugs, particularly in the fields of antiviral treatments for HIV, hepatitis B, hepatitis C, and influenza. Founded in 1987, Gilead has a rich history of pioneering antiviral therapies and has played a significant role in transforming the treatment landscape for HIV and hepatitis C.

Recent Posts by Gilead Sciences

1-20 of 3341